TABLE 4: Details of Thalidomide usage.
Thalidomide | Number |
---|---|
Severity mentioned | |
ENL | 35(83) |
Severe ENL | 7(17) |
Duration of treatment | |
Not mentioned | 15(35.71) |
< 3 Months (treatment stopped) | 6(14.29) |
-3 months | 17(40.48) |
> 3 months | 3(7.14) |
Thalidomide and steroids indications | |
No neuritis | 21(51) |
Neuritis- Thalidomide + steroids | 16(39) |
Neuritis- Thalidomide alone | 4(9.75) |
Thalidomide dose | |
Not mentioned | 15(36.58) |
100MG | 3(7.32) |
150MG | 1(2.44) |
200MG | 2(4.88) |
300MG | 18(43.90) |
400MG | 2(4.88) |
Outcome | |
Responded | 24(59) |
Stopped | 17(41) |
Reasons for stopping Thalidomide | |
NR-other drugs used | 8(47) |
Peripheral neuropathy | 2(12) |
DVT | 4(23) |
Pregnancy | 1(6) |
Intolerance | 1(6) |
Died | 1(6) |